INTRODUCTIONEczema, or atopic dermatitis (AD), is a common skin condition which is estimated to affect >31 million people in United States, with up to 25% of children and almost 10%…
Read More
INTRODUCTIONEczema- or atopy-prone skin frequently has an ineffective skin barrier, which can lead to redness, irritation, and dryness with periods of remission interspersed with flares.1 When their eczema flares, patients…
Read More
INTRODUCTION Body-focused repetitive disorders (BFRBs) are psychocutaneous disorders that are underrecognized and undertreated. They are characterized by the performance of a specific body-focused repetitive behavior (eg, hair pulling, skin picking,…
Read More
INTRODUCTIONLichen planus is an auto-inflammatory skin disorder marked by intensely pruritic, violaceous papules that commonly affect the extremities of middle-aged adults.1 Though a clear pathogenic mechanism remains unknown, some of…
Read More
INTRODUCTIONTherapeutic Challenge How can we ensure dermatologists practice enhanced antibiotic stewardship to combat antimicrobial resistance and negative consequences of microbiome dysbiosis? Solution We developed a mnemonic ENLIGHTEN to help healthcare…
Read More
INTRODUCTIONOnychomycosis represents the most common nail condition seen in clinical practice amongst adults, comprising 50% of all nail disorders seen in the ambulatory setting.1 Clinically, onychomycosis can present with yellow…
Read More
INTRODUCTIONRosacea has variable clinical presentation consisting of four overlapping phenotypes: erythematotelangiectatic, papulopustular, phymatous, and ocular.1 Rosacea's pathogenesis involves increased cutaneous density of Demodex folliculorum mites, which drive inflammation through activation…
Read More
introductionNemolizumab is a humanized monoclonal antibody directed against the interleukin (IL)-31 receptor alpha chain (IL-31RA) that blocks signaling from neuroimmune cytokine IL-31. While IL-31 was first thought to be primarily…
Read More
IntroductionAcute and chronic skin conditions affecting the appearance of visible skin are associated with both physical and psychological symptoms and lower quality of life.1,2 In individuals with skin of color,…
Read More
INTRODUCTIONAtopic dermatitis (AD), a chronic, relapsing inflammatory disease that affects more than 30 million children and adults in the US, disproportionally impacts African American (AA) and Hispanic children, with a…
Read More
INTRODUCTIONPsoriasis is a significant health and economic burden. In the United States, the prevalence of psoriasis is estimated to be 7.4 million, which accounts for ~2.2% of the population, with…
Read More
INTRODUCTIONLong-term maintenance of clear skin is a primary treatment goal for most patients with psoriasis. Ineffective response or loss of response to systemic therapy necessitates a change in treatment. In…
Read More
